Link between drug absorption solubility and permeability measurements in Caco-2 cells

Journal of Pharmaceutical Sciences

Volumn 87, Issue 12, 1998, Pages 1604-1607

  Fade, Vaishali ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROTHIAZIDE; CIMETIDINE; DILTIAZEM; EPHEDRINE; FUROSEMIDE; NAPROXEN; PHENYTOIN; PROPRANOLOL; SALICYLIC ACID;

ARTICLE; DRUG ABSORPTION; DRUG PENETRATION; DRUG SOLUBILITY; HUMAN; HUMAN CELL; PH;

EID: 0031742986     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js980111k     Document Type: Article

References (24)

1. Gibaldi, M. Gastrointestinal absorption -Physicochemical considerations. In Biopharmaceutics and Clinical Pharmacokinetics, Lea and Febiger: Philadelphia, 1991; pp 40-60.
2. Clements, J. A.; Heading, R. C.; Nimmo, W. S.; Prescott, L. F. Kinetics of acetaminophen absorption and gastric emptying in man. Clin. Pharmacol. Ther. 1978, 24, 420.
3. Hunt, J. N.; Knox, M. T. Regulation of gastric emptying. In Handbook of Physiology; American Physiology Society: Washington, D.C., 1968.
4. Meyer, J. H.; Dressman, J.; Fink, A. S.; Amidon, G. Effect of size and density on canine gastric emptying of nondigestible solids. Gastroenterology 1985, 89, 805-813.
5. Crouthamel, W.; Doluisio, J. T.; Johnson, R. E.; Diamond, L. Effect of mesenteric blood flow on intestinal drug absorption. J. Pharm. Sci. 1970, 59, 878-879.
6. Gault, H.; Kalra, J.; Ahmed, M.; Kepkay, D.; Barrowman, J. Influence of gastric pH on digoxin biotransformation. I. Intragastric hydrolysis, din. Pharmacol. Ther. 1980,27, 16.
7. Amidon, G. L.; Lennernas, H.; Shah, V. P.; Crison, J. R. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 1995, 12, 413-420.
8. Hilgers, A. R.; Conradi, R. A.; Burton, P. S. Caco-2 monolayers as a model for drug transport across the intestinal mucosa. Pharm. Res. 1990, 7, 902-910.
9. Wilson, G.; Hassan, I. F.; Dix, C. J.; Williamson, I.; Shah, R.; Mackay, M. Transport and permeability properties of human Caco-2 cells: An in vitro model of the intestinal epithelial cell barrier. J. Controlled Release 1990, 11, 2540.
10. Artursson, P. Epithelial transport of drugs in cell culture. I. A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells. J. Pharm. Sci. 1990, 79, 476-482.
11. Cogburn, J. N.; Donovan, M.; Schasteen, C. A model of human small intestinal absorptive cells. 1. Transport barrier. Pharm. Res. 1991, 8, 210-216.
12. Hidalgo, I. J.; Raub, T. J.; Borchardt, R. T. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology 1989, 96, 736-749.
13. Rousset, M. The human colon carcinoma cell lines HT-29 and Caco-2: Two in vitro models for study of intestinal differentiation. Biochimie 1986, 68, 1035-1040.
14. Pinto, M.; Leon-Robine, S.; Appay, M. D.; Kedinger, M.; Triadou, N.; Dussaulx, E.; Lacroix, B.; Assmann-Simon, P.; Haffen, K.; Fogh, J.; Zweibaum, A. Enterocyte-like differentiation and polarization of the human colon carcinoma cell line Caco-2 in culture. Biol. Cell. 1983, 47, 323-330.
15. Pade, V.; Stavchansky, S. Estimation of the relative contribution of the transcellular and paracellular pathway to the transport of passively absorbed drugs in the Caco-2 cell culture model. Pharm. Res. 1997, 14:(9), 1210-1215.
16. Skelly, J. P.; Van Buskirk, G. A.; Savello, D. R.; Amidon, G. L.; Arbit, H. M.; Dighe, S.; Fawzi, M. B.; Gonzalez, M. A.; Malick, A. W.; Malinowski, H.; Nedich, R.; Peck, G. E. Scaleup of immediate release dosage forms. Pharm. Res. 1993, 10, 313-316.
17. Goodman, L. S.; Gilman, A.; Rail, T. W.; Nies, A. S.; Taylor, P. Goodman and Oilman's The Pharmacological Basis of Therapeutics, Pergamon: New York, 1990.
18. Mummaneni, V.; Dressman, J. B. Intestinal uptake of cimetidine and ranitidine in rats. Pharm. Res. 1994, 11, 1599-1604.
19. Dressman, J. B.; Fleisher, D.; Amidon, G. L. Physicochemical model for dose dependent drug absorption. J. Pharm. Sci. 1984, 73, 1274-1279.
20. Ritschel, W. A.; Menon, W. A.; Sakr, A. Biopharmaceutic evaluation of furosemide as a potential candidate for a modified release peroral dosage form. Methods Findings Exp. Clin. Pharmacol. 1991, 13, 629-636.
21. Artursson, P.; Karlsson, J. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem. Biophys. Res. Commun. 1991, 775, 880-885.
22. Rubas, W.; Jezyk, N.; Grass, G. M. Comparison of the permeability characteristics of a human colonie epithelial (Caco-2) cell line to colon of rabbit, monkey, and dog intestine and human drug absorption. Pharm. Res. 1993, 10, 113118.
23. Chong, S.; Dando, S. A.; Soucek, K. M.; Morrison, R. A. In vitro permeability through Caco-2 cells is not quantitatively predictive of in vivo absorption of pepti de-like drugs absorbed via the dipeptide transporter system. Pharm. Res. 1996, 73, 120-123.
24. Ponto, L. L.; Schoenwald, R. D. Furosemide (furosemide). A pharmacokinetic/pharmacodynamic review (Part I). Clin. Pharmacokinet. 1990, 78, 381-408.